MARKET

FBLG

FBLG

Fibrobiologics
NASDAQ
0.2600
+0.0050
+1.96%
After Hours: 0.2550 -0.005 -1.92% 18:59 12/04 EST
OPEN
0.2533
PREV CLOSE
0.2550
HIGH
0.2699
LOW
0.2501
VOLUME
1.59M
TURNOVER
--
52 WEEK HIGH
2.790
52 WEEK LOW
0.2400
MARKET CAP
18.16M
P/E (TTM)
-0.5407
1D
5D
1M
3M
1Y
5Y
1D
Vanguard Total Stock Market ETF (VTI) Daily Update—12/04/25
TipRanks · 15h ago
VTI ETF Daily Update—12/03/2025
TipRanks · 1d ago
VTI ETF Daily Update—12/02/25
TipRanks · 2d ago
VTI ETF Daily Snapshot—12/01/2025
TipRanks · 3d ago
Weekly Report: what happened at FBLG last week (1124-1128)?
Weekly Report · 3d ago
FibroBiologics Announces That It Has Fully Repaid All Outstanding Amounts Under Its Convertible Promissory Notes Issued To Yorkville
Benzinga · 11/26 13:35
FIBROBIOLOGICS INC - PAYS OFF ALL AMOUNTS OUTSTANDING UNDER CONVERTIBLE NOTES ISSUED TO YA II PN, LTD.
Reuters · 11/26 13:30
FIBROBIOLOGICS ANNOUNCES PAYOFF OF OUTSTANDING DEBT
Reuters · 11/26 13:30
More
About FBLG
FibroBiologics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including wound healing, multiple sclerosis, degenerative disc disease, psoriasis and certain cancers, and potential human longevity applications including thymic involution reversal. Its product candidates include CybroCell, CYMS101 and CYWC628. CybroCell is an allogeneic fibroblast cell-based therapy for degenerative disc disease. This technology is being designed as an alternative method for repairing the cartilage of the intervertebral disc (or any other articular cartilage). It is developing CYMS101 as an allogeneic fibroblast cell-based therapy to treat multiple sclerosis (MS) and has completed the Phase I study. It is developing CYWC628 as an allogeneic fibroblast cell-based therapy for wound healing. Its CYPS317 is used for the treatment of Psoriasis.

Webull offers Fibrobiologics Inc stock information, including NASDAQ: FBLG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FBLG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FBLG stock methods without spending real money on the virtual paper trading platform.